Followers | 66 |
Posts | 474 |
Boards Moderated | 0 |
Alias Born | 02/26/2019 |
![](https://investorshub.advfn.com/uicon/703916.png?cb=1551276737)
Tuesday, March 31, 2020 5:18:12 AM
JT issues statement “we intend to fight, litigate, believe in the IP”
Amrn is/will rethink US strategy pending assumptions of injunction (up to 2 weeks)
Generics likely have API/manufacturing issues would prefer entry until market much bigger/aNDA entry
*****Europe- the company simply says pending but issues weak statement presently just saying open not yet approved *****
So where does that put us here: litigation is lengthy and uncertain. I believe they should win but appeals have less than a 7% chance of reversal. So be real, even if they litigate, take the fight to the courts, stretch it out, the reality is in the US it boils down to the question maximize sales for next 1-2 years while building market, playing into generic hands? That’s exactly what generics want/expect
OR make the really hard decision to tumbleweed US, let it fade while fighting in court and look to monetize Europe/RoW?
As I see it that is the crux of the future and most important decision of this company now. If they drag this on, cry foul, then likely signals they are so immersed in shock that they will be too slow to refocus attention on Europe. This is like war now. Pardon the euphemism but if America is lost the worse thing to do is nurture the loss but instead fight for what’s ahead. Blitz for Europe/RoW. I don’t want to be left holding the bag of a company that will be slow to redirect focus. If they get stuck in this rut, fight, litigate, courts, blah, blah, blah and slowly act international then it will be a happy ending only for generics and bag holders will be left scrambling
That’s the honest to goodness truth here. It’s ugly, it’s hard to swallow but international is now the key. We know Amrn has always said partnering is preferred now instead of partnering they can silver platter it w the US litigation as a sour cherry on top of any bo talk.s.
Be aggressive now. Be laser focused on what’s next for Europe/rest of world.
Suck up the loss. What’s done is done. Now get on with it. Going get tough mentality.
As much as I want heads to roll, that won’t solve this crisis so what they do next matters.
I’ve expressed my concerns to them, predictably no response yet. For any of you still reading I urge you to email IR, voice demands. Voice action, let them know you won’t sit idly by with Europe open and untouched. Our best hope is Europe gets a bidding war. Someone will want it. Someone will pay for a Europe empire. Be smart, this is last leverage now.
Recent AMRN News
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Portugal • GlobeNewswire Inc. • 07/17/2024 08:15:00 PM
- Amarin to Report Second Quarter 2024 Financial Results and Host Conference Call on July 31, 2024 • GlobeNewswire Inc. • 07/17/2024 12:00:00 PM
- Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR) • GlobeNewswire Inc. • 07/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM